Nuveen
CLOV icon

Nuveen’s Clover Health Investments CLOV Stock Holding History

Nuveen’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33M Buy
6,291,699
+5,356,156
+573% +$18.2M 0.01% 956
2026
Q1 		$1.65M Buy
935,543
+52,007
+6% +$113K ﹤0.01% 2348
2025
Q4 		$2.08M Hold
883,536
– – ﹤0.01% 2277
2025
Q3 		$2.7M Sell
883,536
-22,802
-3% -$65.1K ﹤0.01% 2172
2025
Q2 		$2.53M Buy
+906,338
New +$2.98M ﹤0.01% 2196
2023
Q2 		– Sell
-1,041,822
Closed -$880K – 3226
2023
Q1 		$880K Sell
1,041,822
-10,016
-1% -$11K ﹤0.01% 2652
2022
Q4 		$978K Sell
1,051,838
-728,233
-41% -$972K ﹤0.01% 2688
2022
Q3 		$3.03M Buy
1,780,071
+474,829
+36% +$1.24M ﹤0.01% 2173
2022
Q2 		$2.79M Buy
+1,305,242
New +$3.47M ﹤0.01% 2264

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Nuveen's CLOV Position: Q2 2026 in Review

Nuveen increased its Clover Health Investments (CLOV) stake by 573% in Q2 2026, buying an estimated $18.2M and bringing the position to 6,291,699 shares worth $33M. The position accounts for 0.01% of the portfolio, ranked #956.

Nuveen first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Nuveen held 6,291,699 shares of Clover Health Investments worth $33M as of Q2 2026.
  • Nuveen bought 5,356,156 Clover Health Investments shares in Q2 2026, an estimated $18.2M.
  • Clover Health Investments made up 0.01% of Nuveen's portfolio in Q2 2026, its #956 holding.
  • Nuveen first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.